Alternatives to Promise Bio

AI-driven digital twin of embryo development for cell-based therapies.

AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.

AI-driven platform for protein-level disease mapping and drug discovery.

Designs proteins with superior properties using computational analysis, evolutionary insights, and AI.

Computational platform using LLMs trained on biological and chemical data for drug discovery.

AI-powered blood test for early cancer detection and subtyping.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

Omnix Medical is developing a novel platform for advanced wound care management.

Develops a platform for individual drug customization using aptamers for cancer treatment.

Compressing biology to develop the next generation of therapies.

AI-powered insights platform for life sciences and biotech workflows.

Pioneering precision microbiome therapeutics for oncology using CRISPR and synthetic biology.

Revolutionizing prenatal testing with non-invasive fetal DNA analysis from maternal blood.

Cloud-based platform for reproducible computational research in life sciences.

Synthetic biology startup optimizing gene expression for food and biotech applications.

Biopharmaceutical company developing human haploid stem cells for regenerative medicine and disease therapy.

OncoDecipher uses silent mutations in cancer genomes to predict cancer type and survival probability.

Drug discovery and development company using a novel technological approach.

Develops a novel method to predict patient response to immune checkpoint inhibitors in oncology.

Unleashing the power of genomics at scale for biological advances and human health.